Also called personalized medicine, this evolving field makes use of an individual’s genes, lifestyle, environment and other factors to identify unique disease risks and guide treatment decision-making.
Masimo's MightySat Medical is the first FDA-cleared pulse oximeter available to consumers without a prescription, which could disrupt the market for the notoriously inaccurate at-home devices.
MediView’s technologies utilize AR to provide clinicians with 3D “X-ray vision” guidance during minimally invasive procedures and surgeries, while also offering remote collaboration.
Barnabas Health and Robert Wood Johnson Health System have agreed to merge to create New Jersey’s largest healthcare system and one of the largest in the nation.
The Agency for Healthcare Research and Quality (AHRQ) has issued a report that examines the use of health IT in ambulatory care practice redesign and the subsequent impact on patients and provider workflow.
The Agency for Healthcare Research and Quality is launching an initiative to fund a Patient-Centered Outcomes Research (PCOR) Clinical Decision Support (CDS) Learning Network.
The American Hospital Association's Interoperability Advisory Group (IAG) offers priorities to both improve patient care and engage patients in supporting new models of care in its 2015 report "Achieving Interoperability that Supports Care Transformation."
President Barack Obama has asked the U.S. Senate to confirm Andy Slavitt as the administrator of the Centers for Medicare & Medicaid Services (CMS).
The House of Representatives has overwhelmingly passed the 21st Century Cures Act, the broad bill designed to accelerate the development and regulatory approval of medical breakthroughs.
Johnson & Johnson Health and Wellness Solutions, Inc. today announced the release of My Health Discovery™, a new digital mobile health assessment designed to help individuals improve their health.
The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.
The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks.
Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.
